# Specific Use-Result of Spiriva Respimat® in Asthmatics

> **NCT03188120** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 193 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Spiriva Respimat

## Key facts

- **NCT ID:** NCT03188120
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-04
- **Primary completion:** 2018-09-22
- **Final completion:** 2018-11-08
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2019-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188120, "Specific Use-Result of Spiriva Respimat® in Asthmatics". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03188120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*